S. Silvente-poirot and P. M. Cancer, Cholesterol and cancer, in the balance, Science, vol.343, pp.1445-1451, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00968924

G. J. Schroepfer, Oxysterols: modulators of cholesterol metabolism and other processes, Physiol Rev, vol.80, pp.361-554, 2000.

F. Bovenga, C. Sabba, and A. Moschetta, Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer, Cell Metab, vol.21, pp.517-543, 2015.

M. Poirot, R. Soules, A. Mallinger, and F. Dalenc, Silvente-Poirot S. Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3beta,5alpha-diol (OCDO), a tumor promoter and cholesterol metabolite, Biochimie, 2018.

T. J. Berrodin, Q. Shen, E. M. Quinet, M. R. Yudt, L. P. Freedman et al., Identification of 5alpha, 6alpha-epoxycholesterol as a novel modulator of liver X receptor activity, Mol Pharmacol, vol.78, pp.1046-58, 2010.

B. A. Janowski, P. J. Willy, T. R. Devi, J. R. Falck, and D. J. Mangelsdorf, An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha, Nature, vol.383, pp.728-759, 1996.

C. Y. Lin, L. L. Vedin, and K. R. Steffensen, The emerging roles of liver X receptors and their ligands in cancer, Expert Opin Ther Targets, vol.20, pp.61-71, 2016.

L. Gabitova, A. Gorin, and I. Astsaturov, Molecular pathways: sterols and receptor signaling in cancer, Clin Cancer Res, vol.20, pp.28-34, 2014.

O. F. Kuzu, M. A. Noory, and G. P. Robertson, The role of cholesterol in cancer, Cancer Res, vol.76, pp.2063-70, 2016.

N. A. Riobo, Cholesterol and its derivatives in Sonic Hedgehog signaling and cancer, Curr Opin Pharmacol, vol.12, pp.736-777, 2012.

P. Rangarajan, D. Subramaniam, S. Paul, D. Kwatra, K. Palaniyandi et al., Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells, Oncotarget, vol.6, pp.27661-73, 2015.

P. Huang, D. Nedelcu, M. Watanabe, C. Jao, Y. Kim et al., Cellular cholesterol directly activates smoothened in hedgehog signaling, Cell, vol.166, pp.1176-87, 2016.

D. Nedelcu, J. Liu, Y. Xu, C. Jao, and A. Salic, Oxysterol binding to the extracellular domain of Smoothened in Hedgehog signaling, Nat Chem Biol, vol.9, pp.557-64, 2013.

N. Sever, R. K. Mann, L. Xu, W. J. Snell, C. I. Hernandez-lara et al., Endogenous B-ring oxysterols inhibit the Hedgehog component Smoothened in a manner distinct from cyclopamine or side-chain oxysterols, Proc Natl Acad Sci U S A, vol.113, pp.5904-5913, 2016.

M. Voisin, P. De-medina, A. Mallinger, F. Dalenc, E. Huc-claustre et al., Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor, Proc Natl Acad Sci U S A, vol.114, pp.9346-55, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02316171

P. De-medina, M. R. Paillasse, G. Segala, and M. Poirot, Silvente-Poirot S. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands, Proc Natl Acad Sci U S A, vol.107, pp.13520-13525, 2010.

M. Kadmiel and J. A. Cidlowski, Glucocorticoid receptor signaling in health and disease, Trends Pharmacol Sci, vol.34, pp.518-548, 2013.

R. Lappano, A. G. Recchia, D. Francesco, E. M. Angelone, T. Cerra et al., The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor alpha-mediated signaling in cancer cells and in cardiomyocytes, PLoS One, vol.6, p.16631, 2011.

M. Umetani, H. Domoto, A. K. Gormley, I. S. Yuhanna, C. L. Cummins et al., 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen, Nat Med, vol.13, pp.1185-92, 2007.

E. J. Villablanca, L. Raccosta, D. Zhou, R. Fontana, D. Maggioni et al., Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses, Nat Med, vol.16, pp.98-105, 2010.

J. Leignadier, F. Dalenc, M. Poirot, and S. Silvente-poirot, Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death, Biochem Pharmacol, vol.144, pp.18-28, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02380608

C. D. Dusell, M. Umetani, P. W. Shaul, D. J. Mangelsdorf, and D. P. Mcdonnell, 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator, Mol Endocrinol, vol.22, pp.65-77, 2008.

Q. Wu, T. Ishikawa, R. Sirianni, H. Tang, J. G. Mcdonald et al., 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth, Cell Rep, vol.5, pp.637-682, 2013.

E. R. Nelson, S. E. Wardell, J. S. Jasper, S. Park, S. Suchindran et al., 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology, Science, vol.342, pp.1094-1102, 2013.

F. Dalenc, L. Iuliano, T. Filleron, C. Zerbinati, M. Voisin et al., Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study, J Steroid Biochem Mol Biol, vol.169, pp.210-218, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02380620

S. Borgquist, A. Giobbie-hurder, T. P. Ahern, J. E. Garber, M. Colleoni et al., Cholesterol, cholesterol-lowering medication use, and breast cancer outcome in the BIG 1-98 study, J Clin Oncol, vol.35, pp.1179-88, 2017.

N. Simigdala, Q. Gao, S. Pancholi, H. Roberg-larsen, M. Zvelebil et al., Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer, Breast Cancer Res, vol.18, p.58, 2016.

H. Parada, S. E. Steck, P. T. Bradshaw, L. S. Engel, K. Conway et al., Grilled, barbecued, and smoked meat intake and survival following breast cancer, J Natl Cancer Inst, vol.109, 2017.

T. Fiolet, B. Srour, L. Sellem, E. Kesse-guyot, B. Alles et al., Consumption of ultra-processed foods and cancer risk: results from Nutri-Net-Sante prospective cohort, BMJ, vol.360, p.322, 2018.

A. R. Vieira, L. Abar, D. Chan, S. Vingeliene, E. Polemiti et al., Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR Continuous Update Project, Ann Oncol, vol.28, pp.1788-802, 2017.

E. H. Allott and S. D. Hursting, Obesity and cancer: mechanistic insights from transdisciplinary studies, Endocr Relat Cancer, vol.22, pp.365-86, 2015.

G. Segala, P. De-medina, L. Iuliano, C. Zerbinati, M. R. Paillasse et al., 5,6-Epoxy-cholesterols contribute to the anticancer pharmacology of tamoxifen in breast cancer cells, Biochem Pharmacol, vol.86, pp.175-89, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00822322

P. De-medina, M. R. Paillasse, G. Segala, M. Voisin, L. Mhamdi et al., Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties, Nat Commun, vol.4, p.1840, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00823974

G. Segala, M. David, P. De-medina, M. C. Poirot, N. Serhan et al., Dendrogenin A drives LXR to trigger lethal autophagy in cancers, Nat Commun, vol.8, 1903.
URL : https://hal.archives-ouvertes.fr/inserm-02380591

M. Touvier, P. Fassier, M. His, T. Norat, D. S. Chan et al., Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies, Br J Nutr, vol.114, pp.347-57, 2015.

M. F. Tavazoie, I. Pollack, R. Tanqueco, B. N. Ostendorf, B. S. Reis et al., LXR/ApoE activation restricts innate immune suppression in cancer, Cell, vol.172, pp.825-865, 2018.

C. Y. Lin and J. A. Gustafsson, Targeting liver X receptors in cancer therapeutics, Nat Rev Cancer, vol.15, pp.216-240, 2015.

Y. B. Dai, Y. F. Miao, W. F. Wu, Y. Li, D. 'errico et al., Ablation of Liver X receptors alpha and beta leads to spontaneous peripheral squamous cell lung cancer in mice, Proc Natl Acad Sci U S A, vol.113, pp.7614-7623, 2016.

G. Lo-sasso, F. Bovenga, S. Murzilli, S. L. , D. Tullio et al., Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice, Gastroenterology, vol.144, pp.1497-507, 2013.

A. J. Pommier, J. Dufour, G. Alves, E. Viennois, D. Boussac et al., Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice, Cancer Res Sandrine Silvente-Poirot, vol.9, pp.4803-4808, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01934521